Biopharma Absci Prices US$200 Million IPO

Synthetic biology company Absci Corporation began trading on the Nasdaq Global Select Market today under the symbol “ABSI”. The firm’s initial public offering is looking to raise US$200.0 million and is expected to close on July 26, 2021.

The offering consists of 12,500,000 common shares selling at US$16.00 per share. This puts the company valuation at approximately US$1.5 billion.

The company granted a 30-day over-allotment option to purchase additional 1,875,000 common shares at the same IPO price, potentially bringing total offering proceeds up to US$230.0 million. J.P. Morgan, Credit Suisse, BofA Securities, Cowen, and Stifel are all acting as joint bookrunners for the said offering.

The Washington-based biopharma company uses technology to develop the potential role of proteins in therapeutics.


Information for this briefing was found via Sedar and Absci. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Gold Could Easily Double Again in This Run!? | Dan Wilton – First Mining Gold

$3300 GOLD: Every $100 Rise in Gold Means Pure Profit |  Ross Beaty – Equinox Gold

First Majestic Silver: The Santo Nino Discovery

Recommended

Emerita Resources Intends To Appeal Exploitation License Granted To Minera Los Frailes

First Majestic Silver: The Santo Nino Discovery

Related News

Wealth Management SPAC Everest Consolidator Acquisition Prices US$150 Million IPO

Special purpose acquisition company Everest Consolidator Acquisition Corporation (NYSE: MNTN.U) went public on Wednesday on...

Friday, November 26, 2021, 01:54:00 PM

Israeli Tech Firm SaverOne Set To Close US$13 Million Nasdaq IPO

Transportation tech platform SaverOne 2014 Ltd. (Nasdaq: SVRE, SVREW) started trading on the Nasdaq on...

Tuesday, June 7, 2022, 02:22:00 PM

Energy SPAC Energem Seeks To Raise US$100 Million In IPO

Special purpose acquisition company Energem Corp. (Nasdaq: ENCPU) went public on the Nasdaq Global Market...

Tuesday, November 16, 2021, 02:10:00 PM

Electric Vehicle Maker Iconiq Motors To Be Taken Public In A US$2.5 Billion SPAC Merger

Electric vehicle company Iconiq Motors entered into a definitive business combination agreement with special purpose...

Monday, April 18, 2022, 02:24:00 PM

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM